nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—FGF2—Angiogenesis—TIMP2—intracranial aneurysm	0.163	0.163	CbGpPWpGaD
Sirolimus—MTOR—EGFR-dependent Endothelin signaling events—EDNRA—intracranial aneurysm	0.0896	0.0896	CbGpPWpGaD
Sirolimus—FGF2—Cardiac Progenitor Differentiation—SOX17—intracranial aneurysm	0.0734	0.0734	CbGpPWpGaD
Sirolimus—MTOR—RANKL/RANK Signaling Pathway—CTSK—intracranial aneurysm	0.0271	0.0271	CbGpPWpGaD
Sirolimus—EIF4E—BDNF signaling pathway—NCF1—intracranial aneurysm	0.025	0.025	CbGpPWpGaD
Sirolimus—FGF2—Angiogenesis—NOS3—intracranial aneurysm	0.0242	0.0242	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—TIMP2—intracranial aneurysm	0.0239	0.0239	CbGpPWpGaD
Sirolimus—FGF2—Angiogenesis—MMP9—intracranial aneurysm	0.0194	0.0194	CbGpPWpGaD
Sirolimus—EIF4E—Leptin signaling pathway—NOS3—intracranial aneurysm	0.0175	0.0175	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—ELN—intracranial aneurysm	0.017	0.017	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.0168	0.0168	CbGpPWpGaD
Sirolimus—MTOR—VEGFR2 mediated vascular permeability—NOS3—intracranial aneurysm	0.0159	0.0159	CbGpPWpGaD
Sirolimus—FGF2—Syndecan-4-mediated signaling events—MMP9—intracranial aneurysm	0.0154	0.0154	CbGpPWpGaD
Sirolimus—FGF2—Angiopoietin receptor Tie2-mediated signaling—MMP2—intracranial aneurysm	0.0144	0.0144	CbGpPWpGaD
Sirolimus—EIF4E—Validated targets of C-MYC transcriptional activation—MMP9—intracranial aneurysm	0.0135	0.0135	CbGpPWpGaD
Sirolimus—FGF2—Angiopoietin receptor Tie2-mediated signaling—NOS3—intracranial aneurysm	0.0135	0.0135	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—STARD13—intracranial aneurysm	0.0134	0.0134	CbGpPWpGaD
Sirolimus—MTOR—VEGFA-VEGFR2 Pathway—NCF1—intracranial aneurysm	0.0131	0.0131	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.0128	0.0128	CbGpPWpGaD
Sirolimus—MTOR—Signaling by VEGF—NCF1—intracranial aneurysm	0.0124	0.0124	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—CTSS—intracranial aneurysm	0.0113	0.0113	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—CTSK—intracranial aneurysm	0.0104	0.0104	CbGpPWpGaD
Sirolimus—MTOR—BDNF signaling pathway—NCF1—intracranial aneurysm	0.0103	0.0103	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—CCL2—intracranial aneurysm	0.01	0.01	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—STARD13—intracranial aneurysm	0.00986	0.00986	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—SLC25A16—intracranial aneurysm	0.00976	0.00976	CbGpPWpGaD
Sirolimus—MTOR—Oncostatin M Signaling Pathway—CCL2—intracranial aneurysm	0.00908	0.00908	CbGpPWpGaD
Sirolimus—FGF2—Endochondral Ossification—MMP9—intracranial aneurysm	0.00886	0.00886	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—CTSB—intracranial aneurysm	0.00861	0.00861	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—TIMP1—intracranial aneurysm	0.00789	0.00789	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—STARD13—intracranial aneurysm	0.00747	0.00747	CbGpPWpGaD
Sirolimus—FGF2—Disease—SLC25A16—intracranial aneurysm	0.0074	0.0074	CbGpPWpGaD
Sirolimus—MTOR—Leptin signaling pathway—NOS3—intracranial aneurysm	0.00722	0.00722	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—MMP9—intracranial aneurysm	0.00717	0.00717	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CTSS—intracranial aneurysm	0.00634	0.00634	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CTSS—intracranial aneurysm	0.00605	0.00605	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00588	0.00588	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CTSK—intracranial aneurysm	0.00583	0.00583	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CTSS—intracranial aneurysm	0.00581	0.00581	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CTSK—intracranial aneurysm	0.00557	0.00557	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—STARD13—intracranial aneurysm	0.00555	0.00555	CbGpPWpGaD
Sirolimus—MTOR—Disease—SLC25A16—intracranial aneurysm	0.00549	0.00549	CbGpPWpGaD
Sirolimus—MTOR—VEGFA-VEGFR2 Pathway—NOS3—intracranial aneurysm	0.00543	0.00543	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CTSK—intracranial aneurysm	0.00535	0.00535	CbGpPWpGaD
Sirolimus—MTOR—CXCR4-mediated signaling events—MMP9—intracranial aneurysm	0.00529	0.00529	CbGpPWpGaD
Sirolimus—MTOR—Signaling by VEGF—NOS3—intracranial aneurysm	0.00513	0.00513	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CTSB—intracranial aneurysm	0.00483	0.00483	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—NCF1—intracranial aneurysm	0.0048	0.0048	CbGpPWpGaD
Sirolimus—FGF2—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.00471	0.00471	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CTSB—intracranial aneurysm	0.00461	0.00461	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CTSS—intracranial aneurysm	0.00449	0.00449	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CTSB—intracranial aneurysm	0.00442	0.00442	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—NCF1—intracranial aneurysm	0.0044	0.0044	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CTSS—intracranial aneurysm	0.00431	0.00431	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CTSK—intracranial aneurysm	0.00413	0.00413	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.00408	0.00408	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CTSK—intracranial aneurysm	0.00397	0.00397	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—SLC25A16—intracranial aneurysm	0.00395	0.00395	CbGpPWpGaD
Sirolimus—MTOR—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.0039	0.0039	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP2—intracranial aneurysm	0.00379	0.00379	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—CST3—intracranial aneurysm	0.00374	0.00374	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—SLC25A16—intracranial aneurysm	0.00363	0.00363	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CTSS—intracranial aneurysm	0.00352	0.00352	CbGpPWpGaD
Sirolimus—MTOR—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.0035	0.0035	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CTSB—intracranial aneurysm	0.00342	0.00342	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—CCL2—intracranial aneurysm	0.00335	0.00335	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CTSB—intracranial aneurysm	0.00328	0.00328	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—NCF1—intracranial aneurysm	0.00327	0.00327	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—NCF1—intracranial aneurysm	0.00325	0.00325	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CTSK—intracranial aneurysm	0.00324	0.00324	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—MMP2—intracranial aneurysm	0.00319	0.00319	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—AGER—intracranial aneurysm	0.00312	0.00312	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NCF1—intracranial aneurysm	0.00311	0.00311	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—AGER—intracranial aneurysm	0.00297	0.00297	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—EDNRA—intracranial aneurysm	0.00293	0.00293	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP9—intracranial aneurysm	0.00285	0.00285	CbGpPWpGaD
Sirolimus—FGF2—Disease—CST3—intracranial aneurysm	0.00283	0.00283	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CTSB—intracranial aneurysm	0.00268	0.00268	CbGpPWpGaD
Sirolimus—FGF2—Immune System—NCF1—intracranial aneurysm	0.00267	0.00267	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—SLC25A16—intracranial aneurysm	0.00262	0.00262	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ASAH1—intracranial aneurysm	0.00262	0.00262	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CTSS—intracranial aneurysm	0.00261	0.00261	CbGpPWpGaD
Sirolimus—FGF2—Disease—NCF1—intracranial aneurysm	0.00247	0.00247	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CTSK—intracranial aneurysm	0.00241	0.00241	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ASAH1—intracranial aneurysm	0.0024	0.0024	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—MMP2—intracranial aneurysm	0.0023	0.0023	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NCF1—intracranial aneurysm	0.00228	0.00228	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—AGER—intracranial aneurysm	0.00221	0.00221	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—EDNRA—intracranial aneurysm	0.00215	0.00215	CbGpPWpGaD
Sirolimus—MTOR—Disease—CST3—intracranial aneurysm	0.0021	0.0021	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CTSB—intracranial aneurysm	0.00199	0.00199	CbGpPWpGaD
Sirolimus—MTOR—Immune System—NCF1—intracranial aneurysm	0.00198	0.00198	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—SLC25A16—intracranial aneurysm	0.00198	0.00198	CbGpPWpGaD
Sirolimus—MTOR—Disease—NCF1—intracranial aneurysm	0.00183	0.00183	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ASAH1—intracranial aneurysm	0.00174	0.00174	CbGpPWpGaD
Sirolimus—FGF2—Immune System—AGER—intracranial aneurysm	0.00173	0.00173	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—MMP9—intracranial aneurysm	0.00173	0.00173	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NCF1—intracranial aneurysm	0.00173	0.00173	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—EDNRA—intracranial aneurysm	0.00163	0.00163	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CCL2—intracranial aneurysm	0.00145	0.00145	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—NOS3—intracranial aneurysm	0.00135	0.00135	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ASAH1—intracranial aneurysm	0.00131	0.00131	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—NOS3—intracranial aneurysm	0.00129	0.00129	CbGpPWpGaD
Sirolimus—MTOR—Immune System—AGER—intracranial aneurysm	0.00129	0.00129	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NCF1—intracranial aneurysm	0.00128	0.00128	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	0.00122	0.00122	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—EDNRA—intracranial aneurysm	0.00121	0.00121	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CCL2—intracranial aneurysm	0.00106	0.00106	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—MMP9—intracranial aneurysm	0.00103	0.00103	CbGpPWpGaD
Sirolimus—FGF2—Disease—NOS3—intracranial aneurysm	0.00102	0.00102	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—NOS3—intracranial aneurysm	0.000945	0.000945	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	0.000808	0.000808	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CCL2—intracranial aneurysm	0.000803	0.000803	CbGpPWpGaD
Sirolimus—MTOR—Disease—NOS3—intracranial aneurysm	0.000759	0.000759	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MMP9—intracranial aneurysm	0.000758	0.000758	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—NOS3—intracranial aneurysm	0.000716	0.000716	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CCL2—intracranial aneurysm	0.000596	0.000596	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MMP9—intracranial aneurysm	0.000574	0.000574	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—NOS3—intracranial aneurysm	0.000546	0.000546	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—NOS3—intracranial aneurysm	0.000531	0.000531	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—NOS3—intracranial aneurysm	0.000502	0.000502	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MMP9—intracranial aneurysm	0.000426	0.000426	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—NOS3—intracranial aneurysm	0.000363	0.000363	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—NOS3—intracranial aneurysm	0.000274	0.000274	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—NOS3—intracranial aneurysm	0.000169	0.000169	CbGpPWpGaD
